Download as pdf or txt
Download as pdf or txt
You are on page 1of 6

American Journal of Ethnomedicine, 2014, Vol. 1, No.

1, 096-101
Available online at http://www.ajethno.com
© American Journal of Ethnomedicine

The Magic of Herbal Curcumin Therapy in


Recurrent Oral Lichen Planus
Sumanth Prasad, Savita Solanki*, Chinmaya BR, Shourya Tandon and
Ashwini B

S.G.T Dental College Gurgaon, Haryana, India

ABSTRACT

Oral lichen planus is a cell-mediated immune condition. It is one of the most


common dermatological disease present in the oral cavity. It is mostly found in
middle aged and elderly Indian population with a prevalence rate of 2.6%. The
purpose of this article is to highlight a case of oral lichen planus affecting a 22-
year-old male without concomitant cutaneous lesions who had been treated earlier
with topical steroid but repeated recurrence of the lesion made us to shift the
treatment from steroid to herbal curcumin which yielded positive results.

Keywords- Oral lichen planus, Curcumin, Herbal therapy.

INTRODUCTION striae are typically located bilaterally on the


buccal mucosa, mucobuccal fold, gingiva,
Oral lichen planus (OLP) is a and less commonly, the tongue, palate, and
lips. The reticular type has been reported to
chronic inflammatory condition
occur significantly more often in men
characterized by mucosal lesions of varying
compared to women and is usually
appearance and severity3. It has a global
asymptomatic7. Erosive, atrophic, or bullous
prevalence of about 0.5% to 2%, with
type lesions cause burning sensation and
prevalence rate of 2.6% in the Indian
pain8.
population2. It occurs more commonly in
The treatment of oral lichen planus is
females with ratio of approximately 2:13,4. It
corticosteroids which are widely used and
tends to be more persistent and more
the dosage depends on the severity of the
resistant to treatment5.
lesion. The frequent use and misuse of
The clinical presentation of OLP
currently used therapeutic agents has led to
ranges from mild painless white keratotic
the evolution of resistant strains of common
lesions to painful erosions and ulcerations.
pathogens as well as increased incidence of
Oral lichen planus is classified into reticular,
adverse effects associated with their usage.
erosive, atrophic, and bullous types6. The
So the search for the alternative medicinal
reticular form is the most common type and
treatment is still going on. Medicinal plants
presents as papules and plaques with
have been used as a traditional treatment
interlacing white keratotic lines (Wickham
agent for numerous human diseases in many
striae) with an erythematous border. The
parts of world. In rural areas of developing

www.ajethno.com
American Journal of Ethnomedicine

countries, they continue to be used as the found at the epithelial-connective tissue


primary source of medicine. About 80% of interface and there were areas of atrophic
people in developing countries use epithelium with saw-tooth rete ridges.
traditional medicines for their health care. Based on the clinical and
histopathological findings, the final
CASE REPORT diagnosis of reticular oral lichen planus was
made.
A 22-year-old male presented with a Treatment was started with a topical
chief complaint of burning sensation on steroid kenacort 0.1%. The patient was
chewing food on both right and left side of instructed to apply a thin layer of ointment
buccal mucosa. The patient reported directly on the lesion three times a day (after
aggravation of the discomfort and sensitivity meals and at bedtime), and not to take
in the buccal mucosa on consumption of anything orally for one hour after its
spicy food and drinks. Local deposits were application, following which he had to rinse
inconsistent with the corresponding lesion. with Chlorhexidine (0.2%) mouthwash for a
No cutaneous lesions were visible. period of one week. Patient was also advised
The patient’s past dental, and family to completely quit the habit of gutkha
histories were found to be not significant. chewing and to avoid spicy food, along with
The patient was fit and healthy and was not a healthy diet, rich in fresh fruits and
taking any medication. He was a non- vegetables. He was educated and motivated
smoker but had a habit of gutkha chewing regarding a proper plaque control regimen.
with a frequency of 2-3 packets of gutkha He was kept on follow up and after a week,
per day since 2 years. dose was tapered. The topical steroid was
The built and appearance of patient withdrawal after 2 weeks. On evaluation
was normal and there was no clinical after 2 weeks there was no lesion. At the end
evidence of lymphadenopathy. On Intra oral of 3 weeks, the patient again reported with
examination, no cutaneous lesions were similar symptoms of burning sensation on
evident other than the interlacing white eating spicy food. On examination, there
keratotic lines (known as Wickham’s striae) was a presence of white patch on the same
with an erythematous border. White area, with Wickham striae, confirming the
radiating striae were present on left buccal reoccurrence of the lesion. Hence, the
mucosa in retro commissural area extending Patient was again started with the same
from 23-26 region. Similarly, the White topical steroid kenacort with same dosage
radiating striae were present on right buccal for one week and then the dose was tapered
mucosa extending from 14-17 region for next one week. The patient was recalled
(Figure 1, 2). The striae were non scrappable after one month of the withdrawal of the
and did not disappear on stretching. topical steroid treatment it was noticed that
Generalized mild to moderate plaque the lesion reoccur at the same area. So,
accumulation and extrinsic stains were alternative herbal curcumin therapy was
present. There were no signs of ulceration. planned to prevent the reoccurrence of the
Routine hematological investigations lesion as curcumin is being used in treating
were done. An incisional biopsy of the lower oral submucous fibrosis and leukoplakia.
left posterior buccal mucosa on histo- Treatment was started again and
pathological examination showed hyper- aimed primarily at reducing the symptoms
parakeratosis of stratified squamous of the patient. The therapeutic regimen for
epithelium and basal cell degeneration. A the first 4 weeks included herbal medication
dense band-like lymphocytic infiltration was with systemic administration of curcumin

Page 096-101
American Journal of Ethnomedicine

capsules. It is administered with a two


divided dosage of 500 mg given twice daily Lichen planus was first described in
for a period of 4 weeks. The patient was the literature by Eramus Wilson in 18699.
recalled every week to evaluate the response The exact etiology of oral lichen planus is
of curcumin on routine follow up. not well understood. However, oral lichen
The patient was advised to planus occurrence is related to a T-cell
completely quit the habit of gutkha chewing mediated immune response. Activation of
and to avoid spicy food, along with a the inflammatory mediator nuclear factor
healthy diet rich in fresh fruit and kappa B10 and the inhibition of the
vegetables. The patient was educated and transforming growth factor control pathway
motivated regarding a proper plaque control may result in hyper-proliferation of
regimen, which included tooth brushing keratinocytes, thereby causing the white
twice daily with a soft brush and toothpaste. lesions in oral lichen planus11. No known
The patient was counseled about the benefits cure exists for oral lichen planus. Treatment
of curcumin and told that many patients modalities in oral lichen planus are still
responded to curcumin at varying doses of empirical. In general, asymptomatic reticular
its usage for treating ehite lesions. and plaque form doesn’t warrant any
On using curcumin at the 1st week pharmacological intervention. There is no
recall visit, the patient reported slight single recommended therapy but
decrease in the size of lesion with no Corticosteroids remain the mainstay of oral
symptoms of discomfort to curcumin. At the lichen planus therapy because of their
2nd week recall visit, further improvement activity in dampening cell-mediated immune
was seen in the regression of lesion. Oral activity, and they can be administered
hygiene instructions were reinforced. topically, intralesionally, or systemically.
During the end of 3rd week follow up, the Topical corticosteroids (in order of
patient was asked to taper the dose with decreasing potency) such as 0.05%
once a day 500 mg curcumin capsule for 2 betamethasone valerate gel, 0.05%
weeks. After 5th week, patient again came to fluocinonide gel, and 0.1% triamcinolone
the department for routine follow up. There acetonide can be used along with Capsule
were no symptoms of discomfort and no Lycostar contains a combination of
clinical sign of the lesion. No side effect was lycopene, vitamin E, and retinoids which
reported after one month of continuous reduces the hyperkeratosis of oral mucosa.
usage of curcumin. After one month, the But they have a disadvantage that prolong
dose was further taper to 250mg of use of topical steroids for a period of greater
curcumin for the next two weeks. Then local than two weeks continuous use may results
application of curcumin paste was started for in mucosal atrophy and secondary
one month. The treatment was withdrawal candidiasis, and may increase the potential
and patient was kept on follow up for 3 of systemic absorption12.
months. On subsequent follow up for 3 Regardless of clinical type, lesions
months on both the sides of buccal mucosa of oral lichen planus undergo periods of
no evidence of lesion was seen (Figure 3, 4) exacerbation and quiescence12. Reported
and patient didn’t show any sign of that the relapse was seen on discontinuation
discomfort. of steroid therapy. The present case, initially
did observe relapse of oral lichen planus to
corticosteroid therapy. Hence the authors
planned to start and observe the response of
DISCUSSION the patient to curcumin. Though very little

Page 096-101
American Journal of Ethnomedicine

scientific information is present on the significant benefit, with no change in the


benefit of using curcumin, the authors appearance of normal mucousa. The
planned to observe the response of the recurrence of the lesion was absent in this
patient. case when the alternative herbal curcumin
In this case report, a patient with was chosen as a choice of treatment. Also,
reticular oral lichen planus was treated with curcumin has advantage over the
both topical steroids followed by herbal corticosteroids as steroids can cause
curcumin therapy. Curcumin is a mucosal atrophy and candidiasis if used
polyphenol derived from curcuma longa repeatedly. Its continuous usage makes the
plant, commonly known as turmeric. The body resistant and there are chances of
components of turmeric are named recurrence of lesion.
curcuminoids, which include mainly
curcumin (diferuloyl methane), demethoxy- CONCLUSION
curcumin, and bisdemethoxy-curcumin. It
has been used extensively in ayurvedic The curcumin is found to be an
medicine for centuries, as it is nontoxic and effective treatment in oral lichen planus
has variety of therapeutic properties even in the cases where topical steroids have
including antioxidant, analgesic, anti- been used and recurrence was seen. It was
inflammatory, antiseptic activity and anti- found to be a good herbal alternative to
carcinogenic activity. The anti-carcinogenic steroids. Further investigations and clinical
effects of curcumin are due to direct trials have been going on curcumin use in
antioxidant and free radical scavenging various pre cancerous lesions and
effects and their ability to indirectly increase conditions.
glutathione levels, thereby aiding in hepatic
detoxification of mutagens and carcinogens. REFERENCES
Curcumin has been shown to suppress
transformation, proliferation, and metastasis 1. Setterfield JF, Black MM, Challacombe SJ.
The management of oral lichen planus. Clin
of tumors. These effects are mediated
Exp Dermatol. 2000; 25:176-182.
through its regulation of various 2. Murti PR, Daftary DK, Bhonsle RB, et al.
transcription factors, growth factors, Malignant potential of oral lichen planus:
inflammatory cytokines, protein kinases, and observations in 722 patients from India. J
other enzymes. It also inhibits proliferation Oral Pathol. 1986; 15(2):71-77.
of cancer cells by arresting them in various 3. Vincent SD, Fotos PG, Baker KA, Williams
phases of the cell cycle and by inducing TP. Oral lichen planus: the clinical, and
Apoptosis13. Research over the last few therapeutic features of 100 cases. Oral Surg
decades has shown that curcumin is a potent Oral Med Oral Pathol. 1990; 70(2):165-
anti-inflammatory agent with strong 171.
therapeutic potential against a variety of 4. Scully C, Beyli M, Ferreiro MC, et al.
Update on oral lichen planus:
cancers.
etiopathogenesis and management. Crit Rev
In this case, we found that the oral Oral Biol Med. 1998; 9(1):86-122.
lichen planus responded well to curcumin. 5. Mollaoglu N. Oral lichen planus: a review.
As the dose was initially started at 1gm for 2 Brit J Oral Maxillofacial Surg 2000;
weeks, and then tapered to 500 mg for next 38(4):370-7.
2 weeks. Further it was tapered to 250 mg 6. Laiejendecker R, Van Joost T, Tank B,
for 2 weeks and followed by 1 month of Oranje AP, Neumann AP. Oral lichen planus
local application. The follow up after 3 in childhood. Pediatr Dematol 2005;
month on last use of curcumin observed 22:299-304.

Page 096-101
American Journal of Ethnomedicine

7. Greenberg MS, Glick M, eds. Burket’s Oral 11. Kartsaidis A, Schreurs O, Axell T,
Medicine. 10th ed. Hamilton: BC Decker Helgeland K, Schenck K. Inhibition of
Inc. 2003:89-95. transforming growth factor- beta/smad
8. Edwards, Kelsch R: Oral Lichen Planus: signaling pathway in the epithelium of oral
Clinical Presentation and Management: J lichen. J Invest Dermatol 2003; 121:1283-
Can Dent Assoc 2002; 68(8):494-9. 90.
9. Scully C, El-com M: Lichen planus: Review 12. Usatine R.P, Tinitigan M. Diagnosis and
and update on pathogenesis. Journal of oral Treatment of Lichen Planus. Am Fam
pathology 1985; 14:431-58. Physician 2011; 84(1):53-60.
10. Santoro A, Majorana A, Bardellini E, Festa 13. Jurenka JS. Anti-inflammatory Properties of
S, Sapelli P, Facchetti F. NF- KappaB Curcumin, a Major Constituent of Curcuma
expression in oral and cutaneous lichen longa: A Review of Preclinical and Clinical
planus. J Pathol 2003; 201:466-72. Research. Altern Med Rev 2009; 14(2):141-
153.

Figure 1. Shows left side of buccal mucosa with Figure 2. Shows right side of buccal mucosa with
oral lichen planus before herbal curcumin oral lichen planus before herbal curcumin
treatment regimen treatment regimen

Page 096-101
American Journal of Ethnomedicine

Page 096-101

You might also like